Wound Management Technologies

WNDM:OTC

Pharmaceuticals: Generic

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2021

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Pharmaceuticals: Generic Founded 1982

Wound Management Technologies, Inc. is a commercial stage company with primary products in the wound care market. It focuses on the distribution of patented collagen product, CellerateRX, which is FDA cleared and reimbursable under medicare part B. It expanded its CellerateRX product line to include CellerateRX surgical products. The company was founded by Scott A. Haire in 1982 and is headquartered in Dallas, TX.

website

Headquarters

Addison

Suite 250

16633 Dallas Parkway

Dallas, TX 75001

1.972.218.0935

Executives

Name	Title	Gender
Scott A. Haire	Founder	Male
John C. Siedhoff	Chairman	Male
Deborah Jenkins Hutchinson	President	Female
Barry E. Constantine	Director-Research & Development	Male
Alec O. Hochstein, PhD	Medical Director	Male
J. Michael Carmena	CFO & Principal Accounting Officer	Male

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Wound Management Technologies - Competitors and Related Companies

How Wound Management Technologies stacks up to its peers in the Pharmaceuticals: Generic industry or with competing business segments.